Supplemental material
Cell Cycle
Volume 21, 2022 - Issue 24
Open access
936
Views
1
CrossRef citations to date
0
Altmetric
Research Paper
Apurinic/apyrimidinic endonuclease triggered doxorubicin-releasing DNA nanoprism for target therapy
Meng Lianga Department of Otolaryngology, Huazhong University of Science and Technology Union Shenzhen Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China
https://orcid.org/0000-0001-7737-5239View further author information
Na Lib College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, ChinaView further author information
, Fei Liua Department of Otolaryngology, Huazhong University of Science and Technology Union Shenzhen Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, ChinaView further author information
, Nan Zenga Department of Otolaryngology, Huazhong University of Science and Technology Union Shenzhen Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, ChinaView further author information
, Changyuan Yub College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, ChinaCorrespondence[email protected]
View further author information
& View further author information
Shuo Lia Department of Otolaryngology, Huazhong University of Science and Technology Union Shenzhen Hospital and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-6025-3948View further author information
Pages 2627-2634
|
Received 14 Dec 2020, Accepted 26 Jul 2022, Published online: 09 Aug 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.